NEU 3.50% $14.05 neuren pharmaceuticals limited

Outside Markets, page-18

  1. 981 Posts.
    lightbulb Created with Sketch. 77
    I found these three people were not only researchers but also investigators on the Neuren Pharmaceuticals clinical trial for Rett syndrome (NNZ-2566) which concluded in 2014. Those people were the lead in rett research. Unfortunately, I didn't found the follow up in 2015/2016 for these guys, anything added are welcome.  Finger cross and GLTAH
    https://www.bcm.edu/people/view/b1708fe6-ffed-11e2-be68-080027880ca6
    https://www.uab.edu/medicine/neurobiology/faculty/39-area-2/peds-neuro-fac/84-apercy
    https://www.researchgate.net/profile/Jeffrey_Neul
    http://www.pedneur.com/article/S0887-8994(15)30314-3/abstract
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.